- Home
- Archives
- 2022
- Vol. 3 Issue 3
- Article
Classification of Mental Stress on a Sports Person Using EEG
Authors
12Department of Sports Technology, Tamilnadu Physical Education and Sports University (TNPESU), Melakkottaiyur, Chennai- 600127, India.
Article Information
- DOI
- No DOI
- Published In
- Volume 3, Issue 3 (2022)
- Published Online
- May-June 2022
- Pages
- 524-531
- Article Type
- Research Article
- Check for updates
- No DOI available for cross-reference
References
[1] R. Yuvaraj, M. Murugappan, and K. Sundaraj, “EEG dynamics in neurological disorders: Parkinson’s disease and stroke,” in IEEE
Student Conference on Research and Development (SCOReD), 2012, pp. 32–37.
[2] T. H. Sanders and M. A. Clements, “Multimodal monitoring for neurological disorders,” in 40th Annual Northeast Bioengineering
Conference (NEBEC), 2014, pp. 1–2.
[3] F. H. L. da Silva, “The impact of EEG/MEG signal processing and modeling in the diagnostic and management of epilepsy,” IEEE
Reviews in Biomedical Engineering, vol. 1, pp. 143–156, 2008.
[4] M. P. Mattson, “Pathways towards and away from Alzheimer’s disease,” Nature, vol. 430, no. 7000, pp. 631–639, 2004
[5] G. F. Chen, T. H. Xu, Y. Yan, Y. R. Zhou, Y. Jiang, K. Melcher, and H. E. Xu, “Amyloid beta: structure, biology and structure-based
therapeutic development.” Acta Pharmacologica Sinica, vol. 38, no. 9, pp. 1205– 1235, 2017.
[6] J. L. Cummings, “Biomarkers in Alzheimer’s disease drug development.” Alzheimers & Dementia the Journal of the Alzheimer's
Association, vol. 7, no. 3, pp. 1218–1222, 2011.
[7] W. E. Klunk, H. Engler, A. Nordberg, Y. Wang, G. Blomqvist, D. P. Holt, M. Bergström, I. Savitcheva, G. F. Huang, and S. Estrada,
“Imaging brain amyloid in Alzheimer’s disease with Pittsburgh Compound-B.” Annals of Neurology, vol. 55, no. 3, pp. 306–319, 2004.
[8] R. J. Bateman, C. Xiong, T. L. Benzinger, A. M. Fagan, A. Goatee, N. C. Fox, D. S. Marcus, N. J. Cairns, X. Xie, and T. M. Blazey,
“Clinical and biomarker changes in dominantly inherited Alzheimer’s disease,” New England Journal of Medicine, vol. 367, no. 9, pp. 795–
804, 2012.
[9] C. S. Herrmann and T. Demiralp, “Human EEG gamma oscillations in neuropsychiatric disorders,” Clinical Neurophysiology Official
Journal of the International Federation of Clinical Neurophysiology, vol. 116, no. 12, pp. 2719–33, 2005.
[10] C. Babiloni, R. G. Ferri, F. Vecchio, G. B. Frisoni, B. Lanuzza, C. Miniussi, F. Nobili, G. Rodriguez, F. Rundo, and A. Cassarino,
“Directionality of EEG synchronization in Alzheimer’s disease subjects.” Neurobiology of Aging, vol. 30, no. 1, pp. 93, 2009.
Student Conference on Research and Development (SCOReD), 2012, pp. 32–37.
[2] T. H. Sanders and M. A. Clements, “Multimodal monitoring for neurological disorders,” in 40th Annual Northeast Bioengineering
Conference (NEBEC), 2014, pp. 1–2.
[3] F. H. L. da Silva, “The impact of EEG/MEG signal processing and modeling in the diagnostic and management of epilepsy,” IEEE
Reviews in Biomedical Engineering, vol. 1, pp. 143–156, 2008.
[4] M. P. Mattson, “Pathways towards and away from Alzheimer’s disease,” Nature, vol. 430, no. 7000, pp. 631–639, 2004
[5] G. F. Chen, T. H. Xu, Y. Yan, Y. R. Zhou, Y. Jiang, K. Melcher, and H. E. Xu, “Amyloid beta: structure, biology and structure-based
therapeutic development.” Acta Pharmacologica Sinica, vol. 38, no. 9, pp. 1205– 1235, 2017.
[6] J. L. Cummings, “Biomarkers in Alzheimer’s disease drug development.” Alzheimers & Dementia the Journal of the Alzheimer's
Association, vol. 7, no. 3, pp. 1218–1222, 2011.
[7] W. E. Klunk, H. Engler, A. Nordberg, Y. Wang, G. Blomqvist, D. P. Holt, M. Bergström, I. Savitcheva, G. F. Huang, and S. Estrada,
“Imaging brain amyloid in Alzheimer’s disease with Pittsburgh Compound-B.” Annals of Neurology, vol. 55, no. 3, pp. 306–319, 2004.
[8] R. J. Bateman, C. Xiong, T. L. Benzinger, A. M. Fagan, A. Goatee, N. C. Fox, D. S. Marcus, N. J. Cairns, X. Xie, and T. M. Blazey,
“Clinical and biomarker changes in dominantly inherited Alzheimer’s disease,” New England Journal of Medicine, vol. 367, no. 9, pp. 795–
804, 2012.
[9] C. S. Herrmann and T. Demiralp, “Human EEG gamma oscillations in neuropsychiatric disorders,” Clinical Neurophysiology Official
Journal of the International Federation of Clinical Neurophysiology, vol. 116, no. 12, pp. 2719–33, 2005.
[10] C. Babiloni, R. G. Ferri, F. Vecchio, G. B. Frisoni, B. Lanuzza, C. Miniussi, F. Nobili, G. Rodriguez, F. Rundo, and A. Cassarino,
“Directionality of EEG synchronization in Alzheimer’s disease subjects.” Neurobiology of Aging, vol. 30, no. 1, pp. 93, 2009.
Related Articles
Share Article
*Instagram doesn't support direct link sharing from web. Copy the link and share it in your Instagram story or post.